{"id":"intravenous-placebo-before-endovascular-thrombectomy","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a placebo comparator used in a Phase 3 randomized controlled trial to establish the baseline effect of endovascular thrombectomy alone versus thrombectomy preceded by intravenous placebo administration. Placebo allows researchers to isolate the true therapeutic benefit of the mechanical thrombectomy procedure by controlling for patient expectations and natural disease progression in acute ischemic stroke.","oneSentence":"Intravenous placebo serves as a control intervention in a clinical trial comparing the efficacy and safety of endovascular thrombectomy with and without placebo pretreatment.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:16:58.323Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute ischemic stroke eligible for endovascular thrombectomy (Phase 3 trial comparator)"}]},"trialDetails":[{"nctId":"NCT05367362","phase":"PHASE2","title":"Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke","status":"WITHDRAWN","sponsor":"State University of New York at Buffalo","startDate":"2025-12-01","conditions":"Acute Ischemic Stroke","enrollment":""},{"nctId":"NCT07389460","phase":"PHASE3","title":"Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":820},{"nctId":"NCT06987305","phase":"PHASE3","title":"Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window","status":"RECRUITING","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2025-10-21","conditions":"Stroke, Acute Ischemic","enrollment":820},{"nctId":"NCT07135089","phase":"PHASE3","title":"Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-11-13","conditions":"Stroke, Ischemic","enrollment":870},{"nctId":"NCT06360458","phase":"PHASE3","title":"Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wan-Jin Chen","startDate":"2024-08-01","conditions":"Acute Ischemic Stroke, Large Infarct Core","enrollment":928},{"nctId":"NCT07202143","phase":"PHASE3","title":"Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia","status":"RECRUITING","sponsor":"YiLin","startDate":"2025-09-01","conditions":"Large Infarct Core, Post-stroke Lymphocytopenia","enrollment":200},{"nctId":"NCT05199194","phase":"PHASE3","title":"Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke","status":"RECRUITING","sponsor":"Hospital Moinhos de Vento","startDate":"2022-05-27","conditions":"Stroke, Ischemic, Stroke, Acute","enrollment":398}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":29,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Intravenous placebo before endovascular thrombectomy","genericName":"Intravenous placebo before endovascular thrombectomy","companyName":"General Hospital of Shenyang Military Region","companyId":"general-hospital-of-shenyang-military-region","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Intravenous placebo serves as a control intervention in a clinical trial comparing the efficacy and safety of endovascular thrombectomy with and without placebo pretreatment. Used for Acute ischemic stroke eligible for endovascular thrombectomy (Phase 3 trial comparator).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}